Kewaunee Scientific Corporation (NASDAQ:KEQU) — Stock Price
Kewaunee Scientific Corporation (NASDAQ:KEQU) is currently trading at $36.41 USD, down 1.81% today. Over the past 52 weeks, shares have ranged between $33.97 and $57.68. This page tracks Kewaunee Scientific Corporation's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Kewaunee Scientific Corporation stock valuation.
Kewaunee Scientific Corporation (KEQU) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Kewaunee Scientific Corporation's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Kewaunee Scientific Corporation Income Statement — Revenue, Profit & Earnings by Year
Kewaunee Scientific Corporation's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | $240.47 Million | $203.75 Million | $219.49 Million | $168.87 Million | $147.47 Million |
| Cost of Revenue | $171.62 Million | $151.70 Million | $183.91 Million | $144.65 Million | $123.48 Million |
| Gross Profit | $68.86 Million | $52.05 Million | $35.59 Million | $24.22 Million | $23.99 Million |
| Research & Development | — | $920.00K | $1.01 Million | $990.00K | $1.41 Million |
| SG&A | $50.19 Million | $37.61 Million | $29.71 Million | $26.62 Million | $26.29 Million |
| Total Operating Expenses | $51.10 Million | $33.77 Million | $30.22 Million | $26.83 Million | $25.31 Million |
| Operating Income | $17.76 Million | $18.28 Million | $3.63 Million | $-2.61 Million | $-1.32 Million |
| EBITDA | $22.76 Million | $18.04 Million | $8.16 Million | $916.00K | $459.00K |
| EBIT | $18.00 Million | $14.92 Million | $5.29 Million | $-1.85 Million | $-2.23 Million |
| Interest Expense | $3.21 Million | $1.80 Million | $1.73 Million | $632.00K | $389.00K |
| Income Before Tax | $14.79 Million | $13.12 Million | $4.50 Million | $-2.48 Million | $-2.62 Million |
| Income Tax Expense | $3.20 Million | $-5.94 Million | $3.14 Million | $3.52 Million | $990.00K |
| Net Income | $11.40 Million | $18.75 Million | $1.36 Million | $-6.00 Million | $-3.61 Million |
Kewaunee Scientific Corporation Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Kewaunee Scientific Corporation's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $194.65 Million | $134.77 Million | $118.90 Million | $118.77 Million | $89.38 Million |
| Total Current Assets | $118.36 Million | $96.82 Million | $87.92 Million | $91.56 Million | $60.46 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | — | — | — |
| Net Receivables | $62.38 Million | $45.06 Million | $46.08 Million | $54.71 Million | $32.88 Million |
| Inventory | $32.85 Million | $20.68 Million | $21.89 Million | $23.80 Million | $16.52 Million |
| Property, Plant & Equipment | — | — | $25.57 Million | $22.69 Million | $25.26 Million |
| Goodwill | $12.49 Million | $0.00 | — | — | — |
| Total Liabilities | $128.41 Million | $78.56 Million | $80.41 Million | $82.59 Million | $47.90 Million |
| Total Current Liabilities | $53.71 Million | $40.78 Million | $40.05 Million | $42.29 Million | $34.18 Million |
| Long-term Debt | $33.95 Million | — | — | — | — |
| Net Debt | $35.21 Million | $-12.27 Million | $4.84 Million | $63.13 Million | $10.94 Million |
| Total Stockholder Equity | $64.46 Million | $54.76 Million | $37.41 Million | $35.69 Million | $41.24 Million |
| Retained Earnings | $58.92 Million | $47.51 Million | $28.76 Million | $28.02 Million | $34.15 Million |
Kewaunee Scientific Corporation Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Kewaunee Scientific Corporation generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | $14.78 Million | $19.56 Million | $-3.79 Million | $-7.88 Million | $912.00K |
| Capital Expenditures | $2.17 Million | $4.37 Million | $4.15 Million | $1.91 Million | $2.40 Million |
| Free Cash Flow | $12.62 Million | $15.19 Million | $-7.94 Million | $-9.79 Million | $-1.49 Million |
| Investing Cash Flow | $-30.90 Million | $-4.37 Million | $-4.15 Million | $-1.91 Million | $-2.40 Million |
| Financing Cash Flow | $7.41 Million | $-3.01 Million | $14.93 Million | $11.03 Million | $1.98 Million |
| Dividends Paid | — | — | — | — | $108.00K |
| Stock-Based Compensation | $1.44 Million | $1.03 Million | $886.00K | $729.00K | $634.00K |
| Depreciation | $4.76 Million | $3.12 Million | $2.87 Million | $2.77 Million | $2.69 Million |
| Change in Cash | $-8.77 Million | $12.12 Million | $6.92 Million | $1.16 Million | $516.00K |
Kewaunee Scientific Corporation Earnings History — EPS Actual vs. Analyst Estimates
Track Kewaunee Scientific Corporation's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 11, 2026 | 0.00 | 0.00 | — |
| Dec 10, 2025 | 0.91 | 0.00 | — |
| Sep 09, 2025 | 1.04 | — | — |
| Jun 25, 2025 | 1.95 | 0.00 | — |
| Mar 04, 2025 | 0.45 | — | — |
| Dec 04, 2024 | 1.01 | — | — |
| Sep 11, 2024 | 0.74 | — | — |
| Jun 26, 2024 | 3.71 | — | — |